Amneal Pharmaceuticals, Inc. (AMRX) ownership: insiders 24% · institutions 46% · index and ETF funds 5% (13F 2026-03-31). Insider activity, 90 days: 4 sales, 0 open-market buys. SEC EDGAR first-party data.
| Holder | Shares | Market Value | % Outstanding | Reported |
|---|---|---|---|---|
| BlackRock | 24519192.00 | $304.77M | 7.7% | 2026-03-31 |
| Vanguard | 20322915.00 | $252.61M | 6.4% | 2026-03-31 |
| TPG GP A, LLC | 12328767.00 | $153.25M | 3.9% | 2026-03-31 |
| Rubric Capital Management LP | 11037589.00 | $137.20M | 3.5% | 2026-03-31 |
| State Street | 6794702.00 | $84.46M | 2.1% | 2026-03-31 |
| Dimensional Fund Advisors | 5690586.00 | $70.72M | 1.8% | 2026-03-31 |
| Morgan Stanley | 4637185.00 | $57.64M | 1.5% | 2026-03-31 |
| Geode Capital Management | 4546048.00 | $56.52M | 1.4% | 2026-03-31 |
| Insider | Transaction | Value | Date |
|---|---|---|---|
| Sell | null | 2026-08-13 | |
| Sell | null | 2026-08-13 | |
| Sell | null | 2026-08-12 | |
| Sell | null | 2026-08-11 | |
| Sell | null | 2026-08-11 | |
| Sell | null | 2026-08-11 | |
| Sell | null | 2026-08-10 | |
| Sell | null | 2026-08-10 |
Back to AMRX overview · AMRX earnings · All congressional trades
Institutional data from SEC Form 13F. Insider data from SEC Form 4. Congressional data from STOCK Act disclosures. Not personalized investment advice.